Navigation Links
Multiple Allergies and Medicines Leave Patients With Mixed Messages
Date:11/8/2013

MCLEAN, Va., Nov. 8, 2013 /PRNewswire-USNewswire/ -- Nasal allergies serious enough for treatment with corticosteroids require diagnosis and ongoing management by board-certified allergists, according to a recent social media survey of patients and caregivers. Conducted by leading nonprofit patient education group Allergy & Asthma Network Mothers of Asthmatics (AANMA), the survey is being presented in scientific sessions at the 70th Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).

People who use or administer corticosteroid nasal sprays to children generally reported having multiple medical conditions and symptoms for which they used multiple prescription and other medications, says Nancy Sander, AANMA founder and survey author. Those whose care came from allergists reported greatest satisfaction with the treatment plan. Nearly all (91.4%) said best outcomes came from seeing a physician; 76.9% choose an allergist.

"Our survey responders were all previously diagnosed and relatively well versed in how to correctly use nasal corticosteroids, but the results show a lot of room for improvement in patient education," says Stanley Fineman, MD, MBA, FACAAI, lead medical investigator for the survey and past president of ACAAI. "It is important to know why you are using an intranasal corticosteroid, when to start and stop using it, how to know if it is meeting treatment expectations, how often to have someone examine the inside of your nose and the reasons why, and how often to have your eyes examined."

"It's not intuitive information or something you know just by reading a label" adds Sander. "You can't do a nasal self-examination at home to see if your nasal tissue is boggy and allergic or sickly like a cold, or if it's infected, deviated or full of sores."

"This study also reinforces that we could all be doing a better job educating patients about medications," Fineman continues. "I'm pleased that ACAAI accepted this study for presentation at our annual scientific meeting. It is time for more education and collaboration among patient advocacy groups such as AANMA and professional organizations such as ACAAI to ensure best outcomes for patients."

Must-Know Corticosteroid Nasal Spray Info:

  • Should be started before allergy season begins.
  • Should not be used to treat cold symptoms.
  • Does not give immediate relief.
  • More isn't better.
  • If you have allergies, see a board-certified allergist and obtain a personalized prevention strategy to outsmart and overcome symptoms with minimal need for medication.
  • Read package instructions. Aim the nasal spray away from nasal septum to help avoid unwanted side effects.
  • If you can't tolerate water-based sprays, dry aerosol sprays may be an option.
  • If you use other corticosteroids, such as eye drops, skin cream, asthma/COPD inhalers, nebulizer solutions or oral medications, talk to your doctor before using a nasal spray corticosteroid, to avoid risk of causing a systemic effect.
  • See your ophthalmologist annually if you are at risk for cataracts.

Results of AANMA's Corticosteroid Nasal Spray Survey are the subject of a poster presentation this weekend at the 2013 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Baltimore. The poster and accompanying abstract were prepared by Dr. Fineman and Emory University School of Medicine allergy fellows Anthony Nguyen, DO, and Marissa Shams, MD, along with AANMA's Nancy Sander and Laurie Ross.

ABOUT AANMA

Allergy & Asthma Network Mothers of Asthmatics (AANMA) is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. AANMA specializes in sharing family-friendly, medically accurate information through its award-winning publications Allergy & Asthma Today magazine and The MA Report newsletter, its web site at www.aanma.org and numerous community outreach programs. Follow AANMA on Facebook at facebook.com/AANMA and on Twitter at twitter.com/AANMA.

Find a board certified allergist (www.AllergyandAsthmaRelief.org) for accurate testing, diagnosis and a personalized treatment plan.

Contact: Laurie Ross
Allergy & Asthma Network
Mothers of Asthmatics
703-795-4142
lross@aanma.org


'/>"/>
SOURCE Allergy & Asthma Network Mothers of Asthmatics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes
2. Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting
3. EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre
4. Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other Oral Multiple Sclerosis Therapies
5. Teva Pharmaceuticals Donates to the National Multiple Sclerosis Society in recognition of Jack Osbourne as He Competes on "Dancing with the Stars"
6. Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions
7. Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idecs Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
8. Genalyte And Barbara Davis Diabetes Center Collaborate To Advance Multiplexed Antigen Panel For Early Diagnosis Of Type 1 Diabetes
9. Emdeon Continues Focus on Patient-Centered Healthcare Solutions; Renews Chain Drug Consortium Contract for Multiple Pharmacy Solutions
10. Physicians Practice Wins Multiple Awards for Digital and Print Excellence
11. Millstone Increases Inspection Capabilities in Multiple Locations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):